Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas

被引:56
作者
King, BE
Chen, C
Locker, J
Kant, J
Okuyama, K
Falini, B
Swerdlow, SH
机构
[1] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA
[2] Univ Perugia, Inst Hematol, I-06100 Perugia, Italy
关键词
BCL-2; BCL-6; CD10; CD138; diffuse large B-cell lymphoma; follicular lymphoma; germinal center;
D O I
10.1038/modpathol.3880226
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Diffuse large B-cell lymphomas (DLBCL) are a biologically and clinically heterogeneous entity. Although some DLBCL represent transformation of follicular lymphomas (FL), the proportion that is of follicular center cell (FCC) origin remains uncertain. Immunophenotypic and genotypic markers used to suggest a FCC origin for a lymphoma (bcl-6 and CD10 expression, lack of CD138 expression, bcl-2 rearrangements [RI) or to subdivide DLBCL (bcl-2 expression, bcl-6 R) were therefore investigated in 22 FL and 44 DLBCL using paraffin section immunostains and Southern blot/polymerase chain reaction analysis. All FL tested were bcl-6+ (19) and CD138- (22) with 16/19 also bcl-2 and CD10+ (classic phenotype), one bcl2+, CD10- (grade III) and two bcl2-, CD10+ (grade II or III). Bcl-2R was identified in 4/5 FL-GrI, 3/6 FL-GrII, and 1/3 FL-GrIII. Bcl-6R was found in 0/5, 2/4, and 0/3 FL, respectively. All but 3/41 DLBCL were bcl-6+ with 17/37 also bcl-2+ and CD10+. Three of these cases were also CD138+. Twelve bcl-6+ cases were bcl-2+, CD10-, six bcl-2-, CD10+, and two bcl-2-, CD10-. The three bcl-6- cases were bcl-2+, CD138- and two were CD10+. Bcl-2R was identified in 5/27 DLBCL with 4/5 bcl-2+, 3/4 tested CD10+ and 4/4 bcl-6+. Bcl-6R was identified in 7/26 including three with a classic FL phenotype. The vast majority of DLBCL in this study have an immunophenotype that supports a FCC origin. Although the proportion of DLBCL that co-expressed bcl-6, CD10 and bcl-2 was lower than for the FL, absence of bcl-2 or CD10 may be associated with higher grade FL. It is also possible that bcl-6 expression is not completely specific for a FCC origin. Only a minority of cases suggested postfollicular differentiation. Only a minority of DLBCL show bcl-2R, suggesting that many have a different molecular pathogenesis than most low-grade FL. Bcl-6R did mot exclude a FCC origin.
引用
收藏
页码:1219 / 1231
页数:13
相关论文
共 115 条
[51]  
Kaufmann O, 1999, AM J CLIN PATHOL, V111, P117
[52]  
Klein U, 1998, IMMUNOL REV, V162, P261
[53]   Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma [J].
Kramer, MHH ;
Hermans, J ;
Wijburg, E ;
Philippo, K ;
Geelen, E ;
van Krieken, JHJM ;
de Jong, D ;
Maartense, E ;
Schuuring, E ;
Kluin, PM .
BLOOD, 1998, 92 (09) :3152-3162
[54]   Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression [J].
Kuppers, R ;
Rajewsky, K ;
Hansmann, ML .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (06) :1398-1405
[55]  
Lai R, 1998, MODERN PATHOL, V11, P864
[56]  
Larocca LM, 1998, BLOOD, V92, P1011
[57]   COMMON ACUTE LYMPHOCYTIC-LEUKEMIA ANTIGEN IS IDENTICAL TO NEUTRAL ENDOPEPTIDASE [J].
LETARTE, M ;
VERA, S ;
TRAN, R ;
ADDIS, JBL ;
ONIZUKA, RJ ;
QUACKENBUSH, EJ ;
JONGENEEL, CV ;
MCINNES, RR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (04) :1247-1253
[58]   High incidence of BCL-6 gene rearrangement in diffuse large B-cell lymphoma of primary gastric origin [J].
Liang, R ;
Chan, WP ;
Kwong, YL ;
Xu, WS ;
Srivastava, G ;
Ho, FCS .
CANCER GENETICS AND CYTOGENETICS, 1997, 97 (02) :114-118
[59]   BCL2 TRANSLOCATION FREQUENCY RISES WITH AGE IN HUMANS [J].
LIU, YF ;
HERNANDEZ, AM ;
SHIBATA, D ;
CORTOPASSI, GA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8910-8914
[60]   Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma [J].
López-Guillermo, A ;
Cabanillas, F ;
McDonnell, TI ;
McLaughlin, P ;
Smith, T ;
Pugh, W ;
Hagemeister, F ;
Rodríguez, MA ;
Romaguera, JE ;
Younes, A ;
Sarris, AH ;
Preti, HA ;
Lee, MS .
BLOOD, 1999, 93 (09) :3081-3087